Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Balchem (BCPC) over the last 16 years, with Q3 2025 value amounting to $172.1 million.

  • Balchem's Cost of Revenue rose 1133.79% to $172.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $650.5 million, marking a year-over-year increase of 533.75%. This contributed to the annual value of $617.5 million for FY2024, which is 46.83% down from last year.
  • As of Q3 2025, Balchem's Cost of Revenue stood at $172.1 million, which was up 1133.79% from $162.4 million recorded in Q2 2025.
  • Balchem's 5-year Cost of Revenue high stood at $175.8 million for Q3 2022, and its period low was $126.9 million during Q1 2021.
  • For the 5-year period, Balchem's Cost of Revenue averaged around $155.4 million, with its median value being $154.6 million (2024).
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 2840.91% in 2022, then plummeted by 1275.78% in 2023.
  • Over the past 5 years, Balchem's Cost of Revenue (Quarter) stood at $149.1 million in 2021, then grew by 9.95% to $163.9 million in 2022, then dropped by 6.22% to $153.7 million in 2023, then decreased by 0.03% to $153.7 million in 2024, then rose by 12.0% to $172.1 million in 2025.
  • Its Cost of Revenue stands at $172.1 million for Q3 2025, versus $162.4 million for Q2 2025 and $162.4 million for Q1 2025.